Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?
Aguado, Carlos
Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer? [electronic resource] - World journal of gastroenterology May 2014 - 6092-101 p. digital
Publication Type: Journal Article; Review
2219-2840
10.3748/wjg.v20.i20.6092 doi
Administration, Oral
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Camptothecin--administration & dosage
Capecitabine
Colorectal Neoplasms--drug therapy
Deoxycytidine--analogs & derivatives
Fluorouracil--analogs & derivatives
Humans
Irinotecan
Neoplasm Metastasis
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Randomized Controlled Trials as Topic
Treatment Outcome
Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer? [electronic resource] - World journal of gastroenterology May 2014 - 6092-101 p. digital
Publication Type: Journal Article; Review
2219-2840
10.3748/wjg.v20.i20.6092 doi
Administration, Oral
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Camptothecin--administration & dosage
Capecitabine
Colorectal Neoplasms--drug therapy
Deoxycytidine--analogs & derivatives
Fluorouracil--analogs & derivatives
Humans
Irinotecan
Neoplasm Metastasis
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Randomized Controlled Trials as Topic
Treatment Outcome